Amarin Corp Plcuk (AMRN) Income from Continuing Operations (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Income from Continuing Operations of 10512000.0 for Q1 2026, up 33.03% year-over-year from 7901870.7 in Q1 2025, and down 758.82% quarter-over-quarter from 1224000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Income from Continuing Operations data on file, last reported at 10512000.0 in Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 10512000.0, up 33.03% year-over-year; the trailing twelve-month figure through Mar 2026 was 33613000.0 (down 109.94% YoY), and the FY2025 annual result was 38798000.0, down 277.89% from the prior year.
  • Income from Continuing Operations eased to 10512000.0 in Q1 2026 per AMRN's latest filing, from 1224000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 110019000.0 in Q4 2022 and troughed at 69956000.0 in Q2 2022.
  • A 5-year average of 6784058.82 and a median of 10512000.0 in 2026 frame the typical range for Income from Continuing Operations.
  • On a YoY basis, Income from Continuing Operations climbed as much as 648.53% in 2022 and fell as far as 1841.14% in 2022.
  • A 5-year view of Income from Continuing Operations shows it stood at 110019000.0 in 2022, then sank by 105.25% to 5781000.0 in 2023, then soared by 503.01% to 23298000.0 in 2024, then slumped by 105.25% to 1224000.0 in 2025, then sank by 758.82% to 10512000.0 in 2026.
  • Business Quant data shows AMRN's Income from Continuing Operations at 10512000.0 in Q1 2026, 1224000.0 in Q4 2025, and 7738000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 3.30 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 5.24 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 697.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -4.21 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 2.02 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 2.71 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.68 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -10.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.51 Mn
Dec 31, 2025 -1.22 Mn
Sep 30, 2025 -7.74 Mn
Jun 30, 2025 -14.14 Mn
Mar 31, 2025 -15.70 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 -25.13 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 -9.95 Mn
Dec 31, 2023 -5.78 Mn
Sep 30, 2023 -19.31 Mn
Jun 30, 2023 -17.56 Mn
Mar 31, 2023 -16.46 Mn
Dec 31, 2022 110.02 Mn
Sep 30, 2022 -5.14 Mn
Jun 30, 2022 -69.96 Mn
Mar 31, 2022 -31.56 Mn
Dec 31, 2021 14.70 Mn
Sep 30, 2021 -13.15 Mn
Jun 30, 2021 7.81 Mn